Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

John Harrington | Aug 10, 2017 at 8:25 AM EDT

Study Says 1 in 12 Doctors Received $46 Million in Payments From Drug Companies Selling Painkillers

One in 12 U.S. doctors received more than $46 million from 2013 to 2015 in payments from drug companies that…

Chris Lange | Aug 9, 2017 at 10:25 AM EDT

Why Acadia Pharma Is One of Wednesday’s Best Earnings Reports

Acadia Pharmaceuticals reported its second-quarter financial results after the markets closed on Tuesday.

Chris Lange | Aug 9, 2017 at 8:40 AM EDT

Mylan Crashes to Multiyear Low on Missed Earnings

Mylan released its most recent quarterly earnings report before the markets opened on Wednesday. Unfortunately, the earnings and guidance weren't…

Chris Lange | Aug 8, 2017 at 11:05 AM EDT

Is This the Turnaround Valeant Pharma Has Been Waiting For?

Valeant Pharmaceuticals reported mixed second-quarter financial results before the markets opened on Tuesday.

Chris Lange | Aug 8, 2017 at 10:55 AM EDT

Why Fibrogen Shares Are Exploding

When FibroGen released its most recent quarterly results after the markets closed on Monday, its was not the most important…

Jon C. Ogg | Aug 7, 2017 at 11:40 AM EDT

Jefferies Sees Big Upside From 4 Upcoming Near-Term Biotech Catalysts

Here are four biotech stocks for which the team of analysts at Jefferies, and analysts at other firms, see big…

Chris Lange | Aug 7, 2017 at 10:40 AM EDT

Horizon Pharma Wins Big in Q2

Horizon Pharma released a better than expected quarterly earnings report before the markets opened on Monday.

Chris Lange | Aug 3, 2017 at 10:35 AM EDT

Agile Therapeutics Tanks on Secondary Offering

Although Agile Therapeutics stock is down year to date, it’s actually more or less doubled since January. So now might…

Chris Lange | Aug 3, 2017 at 9:00 AM EDT

Zealand Pharma Closes in on IPO

Zealand Pharma intends to price nearly 4 million shares at a price that will result in an initial public offering…

Jon C. Ogg | Aug 2, 2017 at 1:20 PM EDT

Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease

A blockbuster drug is about to get a chance to have even higher sales, as the FDA has expanded its…

Chris Lange | Aug 2, 2017 at 12:15 PM EDT

Clementia Pharma Enters the Market With a Bang

Clementia Pharmaceuticals entered the market with a bang, with shares priced above expected price range.

Paul Ausick | Aug 1, 2017 at 7:55 AM EDT

Why Pfizer Earnings Aren’t Exciting Investors

Pharmaceuticals maker Pfizer reported second-quarter earnings before markets opened Tuesday, beating profit estimates by a penny a share, but coming…

Douglas A. McIntyre | Aug 1, 2017 at 6:45 AM EDT

Over 90 Million Americans Used Prescription Opioids in 2015

No wonder there is a national problem with opioid use. A contributing factor has to be that almost 92 Americans used…

Chris Lange | Jul 28, 2017 at 11:10 AM EDT

AbbVie Slips Despite Q2 Earnings Beat

AbbVie reported better-than-expected second-quarter financial results before the markets opened on Friday.

Chris Lange | Jul 28, 2017 at 10:30 AM EDT

Tetraphase Pharma Decides to Reap Profits With Secondary Offering

Tetraphase Pharmaceuticals saw its shares pull back on Friday after the company announced that it has priced a secondary offering.

1 … 159 160 161 162 163 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Study Says 1 in 12 Doctors Received $46 Million in Payments From Drug Companies Selling Painkillers

Why Acadia Pharma Is One of Wednesday’s Best Earnings Reports

Mylan Crashes to Multiyear Low on Missed Earnings

Is This the Turnaround Valeant Pharma Has Been Waiting For?

Why Fibrogen Shares Are Exploding

Jefferies Sees Big Upside From 4 Upcoming Near-Term Biotech Catalysts

Horizon Pharma Wins Big in Q2

Agile Therapeutics Tanks on Secondary Offering

Zealand Pharma Closes in on IPO

Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease

Clementia Pharma Enters the Market With a Bang

Why Pfizer Earnings Aren’t Exciting Investors

Over 90 Million Americans Used Prescription Opioids in 2015

AbbVie Slips Despite Q2 Earnings Beat

Tetraphase Pharma Decides to Reap Profits With Secondary Offering

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

Pete Buttigieg’s 2024 antitrust win just erased 17,000 jobs and the largest U.S. ultra-low-cost ariline

Oil’s Decline Opens the Door on These 4 Sub-$30 Buys

BofA Just Deemed Ulta Beauty a High-Quality Compounder. Time to Buy the 26% Pullback?

The IRA and 401(K) Tax Trap That Catches Retirees off Guard

Is College Still Worth It? Ron Lieber's Advice for Parents Navigating Shifting Job Market

Pete Buttigieg’s 2024 antitrust win just erased 17,000 jobs and the largest U.S. ultra-low-cost ariline

Oil’s Decline Opens the Door on These 4 Sub-$30 Buys

Health and Healthcare Articles

All Health and Healthcare Articles

Study Says 1 in 12 Doctors Received $46 Million in Payments From Drug Companies Selling Painkillers

Why Acadia Pharma Is One of Wednesday’s Best Earnings Reports

Mylan Crashes to Multiyear Low on Missed Earnings

Is This the Turnaround Valeant Pharma Has Been Waiting For?

Why Fibrogen Shares Are Exploding

Jefferies Sees Big Upside From 4 Upcoming Near-Term Biotech Catalysts

Horizon Pharma Wins Big in Q2

Agile Therapeutics Tanks on Secondary Offering

Zealand Pharma Closes in on IPO

Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease

Clementia Pharma Enters the Market With a Bang

Why Pfizer Earnings Aren’t Exciting Investors

Over 90 Million Americans Used Prescription Opioids in 2015

AbbVie Slips Despite Q2 Earnings Beat

Tetraphase Pharma Decides to Reap Profits With Secondary Offering

Stock Market Live May 5, 2026: S&P 500 (SPY) Bounces on Pullback in Oil

Live Nasdaq Composite: Tech Stock Gains Unleashed as Stars Align for Risk-On Trade

Pete Buttigieg’s 2024 antitrust win just erased 17,000 jobs and the largest U.S. ultra-low-cost ariline

Oil’s Decline Opens the Door on These 4 Sub-$30 Buys

BofA Just Deemed Ulta Beauty a High-Quality Compounder. Time to Buy the 26% Pullback?

Featured Reads

The IRA and 401(K) Tax Trap That Catches Retirees off Guard

Is College Still Worth It? Ron Lieber's Advice for Parents Navigating Shifting Job Market